CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −539 | $565.51 | $305K | 49,315 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,347 | $566.56 | $763K | 47,968 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,206 | $567.54 | $684K | 46,762 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −269 | $568.21 | $153K | 46,493 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −680 | $569.71 | $387K | 45,813 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −945 | $570.65 | $539K | 44,868 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,215 | $571.64 | $695K | 43,653 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −410 | $572.48 | $235K | 43,243 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,366 | $573.48 | $783K | 41,877 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −701 | $574.91 | $403K | 41,176 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −663 | $575.72 | $382K | 40,513 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −7,500 | 0 | ||
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −2,000 | 148,288 | ||
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −880 | $572.33 | $504K | 27,996 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,543 | $573.45 | $885K | 26,453 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −442 | $574.09 | $254K | 26,011 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,010 | $575.41 | $581K | 25,001 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,398 | $576.37 | $806K | 23,603 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −687 | $577.27 | $397K | 22,916 |
Page 119 of 121 · 2,404 trades